Novartis - Clinical Research Society

Recent Studies Indicate Eltrombopag is Well Tolerated and Effective

The outcomes of two global studies performed at many trial centers globally demonstrate in a first that eltrombopag is a

EU approval, Novartis, us fda

Novartis ($NVS) has recently suggested that its kick off of recently US FDA accepted heart failure medicine Entresto will be

LCZ696, Novartis, us fda

Switzerland based leading global pharmaceutical company Novartis has obtained approval from the US Food and Drug Administration (FDA) for its

Swiss drug maker Roche continues to be at the top of the heap in oncology sales for several years and

For treating individuals with chronic heart failure (CHF), ACE (angiotensin-converting enzyme) inhibitors are generally the first choice. But a new